SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-13-092593
Filing Date
2013-12-27
Accepted
2013-12-27 13:22:46
Documents
1
Group Members
CLAY B. THORPDOUGLAS REEDHATTERAS VENTURE ADVISORS III, LLCHATTERAS VENTURE AFFILIATES III, L.P.JOHN C. CRUMPLERKENNETH B. LEEROBERT A. INGRAM

Document Format Files

Seq Description Document Type Size
1 SC 13G a13-27192_2sc13g.htm SC 13G 276624
  Complete submission text file 0001104659-13-092593.txt   278265
Mailing Address 343 PHOENIXVILLE PIKE MALVERN PA 19355
Business Address 343 PHOENIXVILLE PIKE MALVERN PA 19355 610-889-9900
TETRALOGIC PHARMACEUTICALS CORP (Subject) CIK: 0001361248 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87773 | Film No.: 131300370
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1822 E NC 54 Ste 250 Durham NC 27713
Business Address 1822 E NC 54 Ste 250 Durham NC 27713 9194840730
Hatteras Ventures Partners III LP (Filed by) CIK: 0001390733 (see all company filings)

IRS No.: 000000000
Type: SC 13G